miRNAs and High-Density Lipoprotein metabolism

Area of Science:

• Cardiovascular Biology
• Lipid Metabolism
• Molecular Medicine

Background:

• Altered lipoprotein metabolism is central to atherogenesis.
• Epidemiological studies linked high-density lipoprotein cholesterol (HDL-c) to reduced cardiovascular risk, but its atheroprotective role is debated.
• Current research emphasizes HDL function over HDL-c levels in disease.

Purpose of the Study:

• To review the role of microRNAs (miRNAs) in regulating HDL metabolism and function.
• To explore the therapeutic potential of targeting miRNAs for cardiovascular disease.
• To highlight the paradigm shift towards HDL function in understanding cardiovascular risk.

Main Methods:

• Literature review of recent research on miRNAs, HDL metabolism, and cardiovascular disease.
• Analysis of studies investigating the impact of miRNAs on HDL biogenesis, lipidation, and clearance.
• Synthesis of findings from human genetics and clinical trials regarding HDL-based therapies.

Main Results:

• MicroRNAs are key regulators of genes involved in HDL metabolism and circulating HDL-c levels.
• Evidence suggests HDL function, not just HDL-c content, is critical for atheroprotection.
• The therapeutic potential of modulating miRNAs for HDL-related diseases is under investigation.

Conclusions:

• MicroRNAs significantly influence HDL metabolism and function, offering novel therapeutic targets.
• Understanding HDL function is crucial for developing effective cardiovascular disease treatments.
• Future research should focus on miRNA-mediated regulation of HDL for novel risk modulators.